Abstract
A drug discovery and optimization platform uncovered effective therapeutic combinations for bortezomib-resistant multiple myeloma.
Funding Information
  • National Science Foundation (CMMI-1350197)
  • National Science Foundation (DMI-0327077)
  • National Science Foundation (CMMI-0856492)
  • National Science Foundation (DMR-1343991)
  • National Cancer Institute (U54CA151880)
  • Ministry of Education - Singapore (MOE2015-T2-2-126)
  • Ministry of Education - Singapore (MOE2014-T3-1-006)
  • Ministry of Education - Singapore (T1-2012 Oct -04)
  • National Medical Research Council (BNIG11nov001)

This publication has 59 references indexed in Scilit: